Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: A long-term follow-up study

International Journal of Radiation Oncology Biology Physics

Volumn 91, Issue 1, 2015, Pages 213-222

  Van Der Pal, Helena J ^a   Van Dijk, Irma W ^a   Geskus, Ronald B ^a   Kok, Wouter E ^a   Koolen, Marianne ^a   Sieswerda, Elske ^a   Oldenburger, Foppe ^a   Koning, Caro C ^a   Van Leeuwen, Flora E ^b   Caron, Huib N ^a   Kremer, Leontien C ^a   Van Dalen, Elvira C ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; DISEASES; ECHOCARDIOGRAPHY; HEART; HOSPITALS; REGRESSION ANALYSIS;

CHILDHOOD CANCERS; CLINICAL COURSE; CONGENITAL HEART DISEASE; EQUIVALENT DOSE; LOGISTIC REGRESSION ANALYSIS; LONG-TERM FOLLOW-UP STUDY; METHODS AND MATERIALS; MULTI VARIABLES;

RADIOTHERAPY;

ANTHRACYCLINE; CISPLATIN; CYCLOPHOSPHAMIDE; IFOSFAMIDE; VINCRISTINE; ANTINEOPLASTIC ANTIBIOTIC;

ADOLESCENT; ADULT; AORTA VALVE DISEASE; ARTICLE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CANCER SURVIVOR; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; EWING SARCOMA; FEMALE; FOLLOW UP; GERM CELL TUMOR; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; NEPHROBLASTOMA; NEUROBLASTOMA; NEWBORN; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; OUTCOME ASSESSMENT; PREVALENCE; PRIMARY TUMOR; PRIORITY JOURNAL; PULMONARY VALVE DISEASE; RADIATION DOSE; RADIATION EXPOSURE; RADIATION FIELD; RADIATION INJURY; RISK ASSESSMENT; RISK FACTOR; SOFT TISSUE SARCOMA; TRICUSPID VALVE; TRICUSPID VALVE DISEASE; VALVULAR HEART DISEASE; CONGENITAL MALFORMATION; DRUG EFFECTS; ECHOGRAPHY; HEART VALVE; HEART VALVE DISEASES; MIDDLE AGED; NEOPLASMS; ORGANS AT RISK; PRESCHOOL CHILD; RADIATION RESPONSE; REGRESSION ANALYSIS; SURVIVOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; ORGANS AT RISK; REGRESSION ANALYSIS; RISK FACTORS; SURVIVORS; YOUNG ADULT;

EID: 84922967155     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.09.010     Document Type: Article

References (35)

1. Gatta G, Zigon G, Capocaccia R, et al. Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer 2009;45:992-1005.
2. Geenen MM, Cardous-Ubbink MC, Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 2007;297:2705-2715.
3. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-1582.
4. Kremer LC, van Dalen EC, Offringa M, et al. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol 2001;19:191-196.
5. Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009;339:b4606.
6. van Dalen EC, van der Pal HJ, Kok WE, et al. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. Eur J Cancer 2006;42:3191-3198.
7. van der Pal HJ, van Dalen EC, van Delden E, et al. High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol 2012;30:1429-1437.
8. van der Pal HJ, van Dalen EC, Hauptmann M, et al. Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. Arch Intern Med 2010;170:1247-1255.
9. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 2008;100:1368-1379.
10. Moller TR, Garwicz S, Barlow L, et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: A population-based study in the Nordic countries. J Clin Oncol 2001;19:3173-3181.
11. Tukenova M, Guibout C, Oberlin O, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol 2010;28:1308-1315.
12. Reulen RC, Winter DL, Frobisher C, et al. Long-term cause-specific mortality among survivors of childhood cancer. JAMA 2010;304:172-179.
13. Cardous-Ubbink MC, Heinen RC, Langeveld NE, et al. Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer 2004;42:563-573.
14. Adams MJ, Hardenbergh PH, Constine LS, et al. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 2003;45:55-75.
15. Adams MJ, Lipsitz SR, Colan SD, et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004;22:3139-3148.
16. Friedlander AH, Sung EC, Child JS. Radiation-induced heart disease after Hodgkin's disease and breast cancer treatment: Dental implications. J Am Dent Assoc 2003;134:1615-1620.
17. Glanzmann C, Kaufmann P, Jenni R, et al. Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 1998;46:51-62.
18. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993;11:1208-1215.
19. Heidenreich PA, Hancock SL, Lee BK, et al. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 2003;42:743-749.
20. Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007;99:365-375.
21. Hull MC, Morris CG, Pepine CJ, et al. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 2003;290:2831-2837.
22. Lund MB, Ihlen H, Voss BM, et al. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: An echocardiographic study. Heart 1996;75:591-595.
23. Stewart JR, Fajardo LF. Radiation-induced heart disease: An update. Prog Cardiovasc Dis 1984;27:173-194.
24. van der Pal HJ, van Dalen EC, Kremer LC, et al. Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: A systematic review. Cancer Treat Rev 2005;31:173-185.
25. van Dijk IW, Oldenburger F, Cardous-Ubbink MC, et al. Evaluation of late adverse events in long-term wilms' tumor survivors. Int J Radiat Oncol Biol Phys 2010;78:370-378.
26. Floyd JD, Nguyen DT, Lobins RL, et al. Cardiotoxicity of cancer therapy. J Clin Oncol 2005;23:7685-7696.
27. Sieswerda E, Mulder RL, van Dijk IW, et al. The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability. J Cancer Surviv 2013.
28. Joiner MC, Bentzen SM. Fractionation: The linear-quadratic approach. In: Joiner MC, van der Kogel A, eds. Basic Clinical Radiobiology. London: Hodder Arnold; 2009:102-117.
29. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009;10:1-25.
30. Hamer JPM, Pieper PG. Praktische Echocardiografie. 2nd ed. Bohn: Stafleu van Loghum; 2009.
31. Lancellotti P, Tribouilloy C, Hagendorff A, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: Aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr 2010;11:223-244.
32. Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: Mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010;11:307-332.
33. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999;83:897-902.
34. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-2496.
35. Nishimura RA, Otto CM, Bonow RO, et al. Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:e57-e185.